Drugs Take Backseat to Seeds at Bayer With Monsanto Acquisition

Drugs Take Backseat to Seeds at Bayer With Monsanto Acquisition Drugs Take Backseat to Seeds at Bayer With Monsanto Acquisition:- In the wake of its $66 billion-acquisition of Monsanto Co., Bayer AG risks starving its lucrative drugs business of the resources it needs to grow. Funded with a combination of […]